{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-211066","form_type":"8-K","ticker":"FBRX","cik":"0001419041","company_name":"Forte Biosciences, Inc.","filed_at":"2024-08-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.991658+00:00","generated_at":"2026-05-31T06:46:32.424198+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Forte Biosciences implements 1-for-25 reverse stock split effective August 28, 2024","bullets":["Reverse stock split at 1-for-25 ratio effective 8:00 a.m. ET on August 28, 2024.","No fractional shares issued; cash paid for fractional shares based on Aug 27 closing price.","CUSIP changed to 34962G 208; trading symbol FBRX unchanged on Nasdaq.","Proportionate adjustments made to equity incentive plans and outstanding awards."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-211066","json":"https://secwatch.observer/filing/0001193125-24-211066.json","markdown":"https://secwatch.observer/filing/0001193125-24-211066.md","text":"https://secwatch.observer/filing/0001193125-24-211066.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1419041/000119312524211066/0001193125-24-211066-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1419041/000119312524211066/d838050d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:46:32.424198+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}